The PE is rich in the mid-50s, but has 20% revenue growth, and they have a revolutionary medical device, an insulin patch. Have a new CEO.
Stock price when the opinion was issued
As of Sep 03, 2026. Market Open.
Build your watch list
Sign in to track investmentsyou care about
Black Swan Dexteritas
Stockchase Premium
Stockchase
CNBC
iA Global Asset Management
The PE is rich in the mid-50s, but has 20% revenue growth, and they have a revolutionary medical device, an insulin patch. Have a new CEO.